These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8835084)

  • 1. Effect of acidosis on bilirubin-lipid extract surfactant interaction.
    Amato M; Schürch S; Bachofen H; Burri PH
    Biol Neonate; 1995; 68(5):301-7. PubMed ID: 8835084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of bilirubin on surface tension properties of lung surfactant.
    Amato M; Schürch S; Grunder R; Bachofen H; Burri PH
    Arch Dis Child Fetal Neonatal Ed; 1996 Nov; 75(3):F191-6. PubMed ID: 8976686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biophysical models in investigations of exogenous surfactant activities on the surface tension and their theurapeutic effectiveness].
    Todorov R; Iordanova A; Georgiev GA; Petkova Kh; Stoimenova E; Georgieva R; Khristova E; Vasiliev Kh; Lalchev Z
    Akush Ginekol (Sofiia); 2007; 46 Suppl 1():29-36. PubMed ID: 18175392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biophysical and physiological properties of a modified porcine surfactant enriched with surfactant protein A.
    Sun B; Curstedt T; Lindgren G; Franzén B; Alaiya AA; Calkovská A; Robertson B
    Eur Respir J; 1997 Sep; 10(9):1967-74. PubMed ID: 9311487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilirubin interactions with phospholipid components of lung surfactant.
    Notter RH; Shapiro DL; Taubold R; Chen J
    Pediatr Res; 1982 Feb; 16(2):130-6. PubMed ID: 6895780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of bilirubin toxicity.
    Amato M
    Eur J Pediatr; 1995; 154(9 Suppl 4):S54-9. PubMed ID: 8529712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structures of pulmonary surfactant films adsorbed to an air-liquid interface in vitro.
    Bachofen H; Gerber U; Gehr P; Amrein M; Schürch S
    Biochim Biophys Acta; 2005 Dec; 1720(1-2):59-72. PubMed ID: 16405864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biophysical activity of animal-derived exogenous surfactants mixed with rifampicin.
    Kolomaznik M; Calkovska A; Herting E; Stichtenoth G
    Adv Exp Med Biol; 2015; 839():31-9. PubMed ID: 25252905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative biophysical study of clinical surfactants using constrained drop surfactometry.
    Zuo YY
    Am J Physiol Lung Cell Mol Physiol; 2024 Oct; 327(4):L535-L546. PubMed ID: 39159363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biophysical and chemical stability of surfactant/budesonide and the pulmonary distribution following intra-tracheal administration.
    Chen CM; Chang CH; Chao CH; Wang MH; Yeh TF
    Drug Deliv; 2019 Dec; 26(1):604-611. PubMed ID: 31204848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dextran reduces surfactant inhibition by meconium.
    Tashiro K; Kobayashi T; Robertson B
    Acta Paediatr; 2000 Dec; 89(12):1439-45. PubMed ID: 11195233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface activity of lipid extract surfactant in relation to film area compression and collapse.
    Schürch S; Schürch D; Curstedt T; Robertson B
    J Appl Physiol (1985); 1994 Aug; 77(2):974-86. PubMed ID: 8002555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of mycobacterial lipids on surface properties of Curosurf: implications for lung surfactant dysfunction in tuberculosis.
    Chimote G; Banerjee R
    Respir Physiol Neurobiol; 2008 Jun; 162(1):73-9. PubMed ID: 18515195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of modified natural surfactant after exposure to fibrinogen in vitro and in an animal model of respiratory distress syndrome.
    Calkovska A; Linderholm B; Haegerstrand-Björkman M; Curstedt T
    Pediatr Res; 2012 Sep; 72(3):262-9. PubMed ID: 22691953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilirubin influence on oxidative lung damage and surfactant surface tension properties.
    Dani C; Martelli E; Tronchin M; Buonocore G; Longini M; Di Filippo A; Giossi M; Rubaltelli FF
    Pediatr Pulmonol; 2004 Sep; 38(3):179-85. PubMed ID: 15274094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of cholesterol and budesonide on biophysical properties of clinical surfactant.
    Zhang H; Wang YE; Neal CR; Zuo YY
    Pediatr Res; 2012 Apr; 71(4 Pt 1):316-23. PubMed ID: 22391630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary SP-A enhances adsorption and appears to induce surface sorting of lipid extract surfactant.
    Schürch S; Possmayer F; Cheng S; Cockshutt AM
    Am J Physiol; 1992 Aug; 263(2 Pt 1):L210-8. PubMed ID: 1514646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations.
    Seeger W; Grube C; Günther A; Schmidt R
    Eur Respir J; 1993 Jul; 6(7):971-7. PubMed ID: 8370446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of budesonide and salbutamol on surfactant properties.
    Palmer D; Schürch S; Belik J
    J Appl Physiol (1985); 2000 Sep; 89(3):884-90. PubMed ID: 10956330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dextran restores albumin-inhibited surface activity of pulmonary surfactant extract.
    Kobayashi T; Ohta K; Tashiro K; Nishizuka K; Chen WM; Ohmura S; Yamamoto K
    J Appl Physiol (1985); 1999 Jun; 86(6):1778-84. PubMed ID: 10368337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.